These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Pharmacokinetics of paclitaxel-containing liposomes in rats. Fetterly GJ, Straubinger RM. AAPS PharmSci; 2003 Nov 21; 5(4):E32. PubMed ID: 15198520 [Abstract] [Full Text] [Related]
3. In vivo pharmacokinetic and tissue distribution studies in mice of alternative formulations for local and systemic delivery of Paclitaxel: gel, film, prodrug, liposomes and micelles. Dhanikula AB, Singh DR, Panchagnula R. Curr Drug Deliv; 2005 Jan 21; 2(1):35-44. PubMed ID: 16305406 [Abstract] [Full Text] [Related]
4. [Studies on hypersensitivity and pharmacokinetics of paclitaxel microemulsion]. He L, Wang GL, Zhang Q. Yao Xue Xue Bao; 2003 Mar 21; 38(3):227-30. PubMed ID: 12830723 [Abstract] [Full Text] [Related]
5. Cremophor-free intravenous microemulsions for paclitaxel II. Stability, in vitro release and pharmacokinetics. Nornoo AO, Chow DS. Int J Pharm; 2008 Feb 12; 349(1-2):117-23. PubMed ID: 17869458 [Abstract] [Full Text] [Related]
6. Comparative preclinical and clinical pharmacokinetics of a cremophor-free, nanoparticle albumin-bound paclitaxel (ABI-007) and paclitaxel formulated in Cremophor (Taxol). Sparreboom A, Scripture CD, Trieu V, Williams PJ, De T, Yang A, Beals B, Figg WD, Hawkins M, Desai N. Clin Cancer Res; 2005 Jun 01; 11(11):4136-43. PubMed ID: 15930349 [Abstract] [Full Text] [Related]
7. Paclitaxel-loaded stealth liposomes: Development, characterization, pharmacokinetics, and biodistribution. Xu Y, Meng H. Artif Cells Nanomed Biotechnol; 2016 Jun 01; 44(1):350-5. PubMed ID: 25162671 [Abstract] [Full Text] [Related]
8. Paclitaxel-loaded niosomes for intravenous administration: pharmacokinetics and tissue distribution in rats. Bayindir ZS, Be AB, Yüksel N. Turk J Med Sci; 2015 Jun 01; 45(6):1403-12. PubMed ID: 26775401 [Abstract] [Full Text] [Related]
12. Pharmacokinetics and biodistribution of paclitaxel loaded in pegylated solid lipid nanoparticles after intravenous administration. Li R, Eun JS, Lee MK. Arch Pharm Res; 2011 Feb 01; 34(2):331-7. PubMed ID: 21380818 [Abstract] [Full Text] [Related]
15. Tissue distribution and pharmacokinetics evaluation of DOMC-FA micelles for intravenous delivery of PTX. Wang F, Zhang D, Zhang Q, Guo S, Zheng D, Hao L, Guo H, Li C. J Drug Target; 2013 Feb 01; 21(2):137-45. PubMed ID: 23046502 [Abstract] [Full Text] [Related]
16. Formulating paclitaxel in nanoparticles alters its disposition. Yeh TK, Lu Z, Wientjes MG, Au JL. Pharm Res; 2005 Jun 01; 22(6):867-74. PubMed ID: 15948030 [Abstract] [Full Text] [Related]
17. Effect of genistein on the pharmacokinetics of paclitaxel administered orally or intravenously in rats. Li X, Choi JS. Int J Pharm; 2007 Jun 07; 337(1-2):188-93. PubMed ID: 17267149 [Abstract] [Full Text] [Related]